Chemical and Pharmaceutical Bulletin · 2006 · 38 citations · 4 references
Life SciencesMicrobiologyPharmacologyDrug DiscoveryMolecular PharmacologyMycologyAntifungal AgentsAntifungal PharmacologyFungal Secondary MetabolitesMedicinal PlantsBioactive Fungal MetabolitesCandida Albicans InfectionFungal Bioactive CompoundsFungal Drug DiscoveryFungal Enzyme InhibitorsNatural Antifungal CompoundsNew Antifungal AgentsNovel Antifungal Drug Development
Two new compounds, 3'-(4''-hydroxy-3'',5''-dimethoxyphenyl)-propyl benzoate (1) and 3'-(4''-hydroxyphenyl)-propyl benzoate (3) together with known compounds, 3'-(4''-hydroxy-3''-methoxyphenyl)-propyl benzoate (2), poilaneic acid (4), farnesyl acetone (5) and 4-hydroxybenzaldehyde (6) were isolated and identified from the branches of Croton hutchinsonianus. Their structures were determined by spectroscopic methods. The three phenylpropyl benzoates (1-3) were found to exhibit antifungal activity against Candida albicans (IC(50) 5.36-11.41 microg/ml). Compounds 1-2 (IC(50) 2.11-4.95 microg/ml) exhibited potent but non-selective activity against the enzymes cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) whereas 3 (IC(50) 1.88 microg/ml) preferentially inhibited the enzyme COX-2.
4
Stephen Hawser, Heather A. Norris, Chad Jessup et al. · Journal of Clinical Microbiology · 1998 · 141 citations · Full text
C18 terpenoid metabolites of the brown alga <i>Cystophora moniliformis</i>
BN Ravi, PT Murphy, R.O. Lidgard et al. · Australian Journal of Chemistry · 1982 · 51 citations